Industries
Designed for regulated life sciences.
Pharmaceutical, biotech and medtech companies, service providers, start-ups and AI companies in regulated environments.
Rx
Pharmaceutical companies
Established quality systems with a high documentation and inspection load.
Typical regulatory focus
EU GMP21 CFR 210/211ICH Q9(R1), Q10PIC/S
Bio
Biotechnology
Fast-growing teams building quality systems while they scale.
Typical regulatory focus
EU GMPICH Q5 seriesICH Q10GCP
MD
Medical device manufacturers
Device-specific quality and risk frameworks.
Typical regulatory focus
ISO 13485ISO 14971EU MDR21 CFR 820
CxO
CDMOs and CROs
Several client requirements, quality agreements and frequent audits.
Typical regulatory focus
Quality agreementsEU GMPGCPClient audits
0→1
Pharma and biotech start-ups
Small teams that need GxP foundations before their first inspection.
Typical regulatory focus
GxP foundationsICH Q10Phase-appropriate GMPGCP
AI
Digital health and AI companies
Software and AI teams entering regulated environments.
Typical regulatory focus
GAMP 5Data integrityEU AI ActISO 14971
Frameworks listed are examples. Applicable requirements depend on product, market and activity.
Regulatory intelligence
Grounded in regulatory knowledge. Designed for real-world work.
Frameworks connect to the domains where professionals apply them. Select a framework or a domain.
⚙ Réseau réglementaire interactif · fourni par le thème, textes dans assets/js/i18n
Regulatory source cardIllustrative example
Source requirement21 CFR 211.192, paraphrased
Unexplained discrepancies and batch failures must be thoroughly investigated, whether or not the batch was distributed. The investigation extends to other batches that may be affected, and a written record is kept.
Interpretation
Correcting an issue on the spot does not remove the need to assess it. The key question is whether other batches or products could be affected.
Educational example
A fill-weight check fails on batch B-2417 and is corrected within minutes. The team still assesses the units filled before the correction and the batches run with the same set-up.
Suggested action
Open a deviation under your site procedure, document immediate actions, assess the impact on related batches and route the record for QA review.
Four layers, four colours. The platform is designed to keep sources, interpretations and suggestions visibly separate. Not legal or regulatory advice.
Let's talk
Shape the future of pharmaceutical compliance with us.
Book a demo of the interactive previews or join the pilot programme.
⚙ Bandeau défilant « Demander une démo » · fourni par le thème, textes dans assets/js/i18n